Study identifies increase in antibiotic-resistant typhoid :

Ciprofloxacin is the first-line drug for treating typhoid fever in many countries in Africa with a high disease burden, but the emergence of non-susceptibility

Related Keywords

Malawi , United Kingdom , Typhis Typhi , Philip Ashton , Care Research United Kingdom , National Institute For Health , Melinda Gates Foundation , Liverpool Wellcome Programme , Wellcome , Malawi Liverpool Wellcome Programme , Queen Elizabeth Central Hospital , Between October , National Institute , Care Research , Newswise , Yphoid Antibiotic Resistant Salmonella , All Journal News , Public Health , University Of Liverpool ,